Alexander's Sells Rego Park I Property for $235.5M
Alexander's entered into an agreement to sell its Rego Park I property to Northwell Health, Inc. The gross purchase price is $235.5M and the net proceeds will be $202M. The property is unencumbered. The property is located at the intersection of Queens Boulevard and Junction Boulevard, adjacent to the Long Island Expressway, in Queens, New York. The Rego Park I property is comprised of a vacant, three-story, 338,000 gross leasable square foot structure built in 1959 and a 1,236 space parking garage, located on 5.9 acres. Alexander's recently vacated the property by relocating tenants to its adjacent Rego Park II shopping center. The financial statement gain will be approximately $147M and the tax gain will be approximately $145M, of which $48M was recognized in 2025 and approximately $97M will be recognized in 2026. The sale is subject to customary closing conditions and is expected to close by the third quarter of 2026.
Trade with 70% Backtested Accuracy
Analyst Views on ALX
About ALX
About the author

- Transaction Value: Alexander has agreed to sell its Rego Park I property to Northwell Health for $235.5 million, expecting net proceeds of approximately $202 million, which will significantly enhance the company's financial position.
- Financial Gains: The transaction is projected to generate a financial statement gain of about $147 million and a tax gain of roughly $145 million, with $48 million recognized in 2025 and about $97 million in 2026, further boosting the company's profitability.
- Timeline for Closure: The sale is expected to close by the third quarter of 2026, subject to customary closing conditions, providing the company ample time to optimize its financial and operational strategies.
- Market Impact: This property sale not only brings substantial cash flow to Alexander but also has the potential to enhance its standing in the small-cap market, attracting more investor attention to its future growth prospects.
- Quarterly Net Income Decline: In Q4 2025, Alexander's reported a net income of $3.8 million, or $0.74 per diluted share, a significant drop from $12.3 million and $2.39 in Q4 2024, indicating challenges in market conditions and reduced profitability.
- Annual Financial Performance Decline: For the year ended December 31, 2025, net income was $28.2 million, or $5.50 per diluted share, down from $43.4 million and $8.46 in 2024, highlighting ongoing pressures on revenue and earnings.
- FFO Metrics Decline: The funds from operations (FFO) for Q4 2025 stood at $12.5 million, or $2.43 per diluted share, a sharp decrease from $20.8 million and $4.06 in the same quarter of 2024, reflecting operational efficiency and asset management challenges.
- Overall Revenue Decrease: Total revenue for 2025 was $213.2 million, down from $226.4 million in 2024, indicating a negative impact from changing market conditions on the company's performance, suggesting a need for strategic reassessment to address future challenges.
Financial Performance: Alexander's has announced its financial results for the fourth quarter, highlighting key metrics and performance indicators.
Revenue and Earnings: The report details revenue figures and earnings per share, showcasing the company's financial health and growth compared to previous quarters.
- Company Performance: Alexander's Q4 adjusted FFO per share is reported at USD 2.43.
- Financial Overview: The financial results indicate a strong performance in the fourth quarter, reflecting the company's operational efficiency.
- Financial Performance: Alexander's Q4 adjusted funds from operations (FFO) reached $12.471 million.
- Investment Insights: The report highlights the company's financial stability and growth potential in the real estate market.
- Company Overview: Alexander's reported a net income of USD 3.824 million for the quarter.
- Financial Performance: The financial results indicate a strong performance in the company's operations during the reporting period.






